Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep disorder characteristics and influencing factors in Parkinson's disease
ChiCTR-CPC-15007223Phase 4Not yet recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rotigotine in Parkinson's disease (PD) (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoint: Polysomnography record. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ChiCTR-CPC-15007223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-CPC-15007223.